Health Care
More on Health Care
Washington, D.C. (Sep. 14, 2020)—Today, House Committee on Oversight and Reform Chairwoman Carolyn B.
Washington, D.C. (Sept. 11, 2020)—Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, Rep. James E. Clyburn, the Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep.
Washington, D.C. – After a 17-month investigation, House and Senate Committee leaders today released a
| Washington, D.C. (Sep. 8, 2020)—Oversight and Reform Committee Chairwoman Carolyn B. Maloney, Select Subcommittee on the Coronavirus Crisis Chairman James E. |
Washington, D.C. (Sept. 1, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, sent a memorandum notifying all Committee Members of her intent to issue a subpoena to AbbVie Inc. for documents as part of the Committee's ongoing investigation of drug company pricing practices, which was initiated by former Chairman Elijah E. Cummings.
Washington D.C. (Aug. 3, 2020)—On Wednesday, August 5, 2020, at 11:00 a.m., Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, will hold a hearing on the health and economic impacts of climate change over the next century if we do not act immediately to limit global warming.
WASHINGTON, D.C. — U.S. Senator Debbie Stabenow (MI) and Chairwoman of the House Oversight Committee Carolyn B. Maloney (NY-12) asked the Government Accountability Office (GAO) to investigate the discovery and development remdesivir – the first drug authorized to treat COVID-19. Gilead, the company that owns the drug, collected more than $22.4 billion in total revenue and generated more than $5.3 billion in profit last year.
Washington, D.C. (July 24, 2020)— Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after President Donald Trump released Executive Orders on drug pricing:
Washington, D.C. – House Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ), House Oversight and Reform Chairwoman Carolyn B.
Washington, D.C. (July 15, 2020)—The Subcommittee on Economic and Consumer Policy held a virtual briefing entitled "Guardrails to Ensure a Safe and Effective COVID-19 Vaccine" to examine the process used by the Food and Drug Administration (FDA) to review and license or authorize any vaccine candidates for the novel coronavirus.